Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity?

The evidence base for the benefits of β-blockers in heart failure with reduced ejection fraction (HFrEF) suggests that higher doses are associated with better outcomes. OBJECTIVES: The aim of this study was to report the proportion of patients receiving optimized doses of β-blockers, outcomes, and f...

Descripción completa

Detalles Bibliográficos
Autores principales: McGinlay, Melanie, Straw, Sam, Byrom-Goulthorp, Rowenna, Relton, Samuel D., Gierula, John, Cubbon, Richard M., Kearney, Mark T., Witte, Klaus K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
ARTICLES: Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613698/
https://www.ncbi.nlm.nih.gov/pubmed/34321430
http://dx.doi.org/10.1097/JCN.0000000000000847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613698/
https://www.ncbi.nlm.nih.gov/pubmed/34321430
http://dx.doi.org/10.1097/JCN.0000000000000847

Ejemplares similares